Eland Oil & Gas Regulatory News (ELA)

30 Apr 2007 09:41

Elan Corporation PLC30 April 2007 ELAN CORPORATION, PLC (the "Company") Annual Information Document for the period from 14 April 2006 up to andincluding 10 April 2007. The Company published its annual financial statementsin respect of the year ended 31 December 2006 on 30 March 2007. This Annual Information Document has been prepared by Elan Corporation, plc inaccordance with the provisions of Part 11 of the Prospectus (Directive 2003/71/EC) Regulations 2005 (S.I. No. 324 of 2005) and has been submitted to the IrishStock Exchange for filing with the Irish Financial Services Regulatory Authority(the Financial Regulator) in accordance with the Prospectus Rules issued by theFinancial Regulator. The Company is publishing this Annual Information Documentvia an RIS today and making it available on its website www.elan.com.The Companydoes not intend to rely solely on the Financial Regulator to publish the AnnualInformation Document. The information referred to in this document was up to date at the time it waspublished but some information may now be out-of-date. To avoid an unnecessarilylengthy document, information is referred to in this document rather thanincluded in full. 1. Announcements made via RNS, a regulatory information service All of the announcements listed below were published via RNS, a RegulatoryInformation Service and are available for viewing on the Irish Stock Exchangewebsite www.ise.ie. Date Announcement10/04/2007 Elan Announces Board of Director Changes30/03/2007 Elan Announces Dates for Upcoming Corporate Events and Filing of Annual Report for Year Ended December 31, 200614/03/2007 Director/PDMR Shareholding13/03/2007 Director/PDMR Shareholding07/03/2007 Elan Announces Webcast of Presentation at the Cowen and Company 27th Annual Healthcare Conference01/03/2007 Director/PDMR Shareholding23/02/2007 Director/PDMR Shareholding22/02/2007 Director/PDMR Shareholding20/02/2007 Elan Reports Fourth Quarter and Full-Year 2006 Financial Results07/02/2007 Holding in Company22/01/2007 Elan Announces Webcast of Fourth Quarter and Full Year 2006 Financial Results02/01/2007 Holding in Company02/01/2007 Holding in Company21/12/2006 Brochure of Particulars20/12/2006 Elan to Present at the 25th Annual JP Morgan Healthcare Conference19/12/2006 Director Change15/12/2006 Elan and Biogen Idec Submit Supplemental Biologics License Application to the FDA for the Approval of TYSABRI(R) as a Treatment for Crohn's Disease15/12/2006 Elan Announces Conversion and Redemption of 6.50% Convertible Guaranteed Notes Due 2008 and Redemption of 7.25% Guaranteed Senior Notes Due 200823/11/2006 Director/PDMR Shareholding22/11/2006 Elan Announces Completion of Offering of US$615 Million Aggregate Principal Amount of Senior Notes20/11/2006 Elan Announces Pricing of US$615 Million Aggregate Principal Amount of Senior Notes17/11/2006 Brochure of Particulars15/11/2006 Annual Report15/11/2006 Annual Report09/11/2006 Elan Announces Proposed Offering of Senior Notes01/11/2006 Elan to Present at the Cowen and Company 7th Annual Global Health Care Conference25/10/2006 Blocklisting Interim Review25/10/2006 Elan Reports Third Quarter 2006 Financial Results24/10/2006 TYSABRI(R) Maintained Remission in Patients with Moderate-to-Severe Crohn's Disease Treated for Longer Than Two Years According to Data Presented This Week18/10/2006 Holding in Company10/10/2006 Notice of Results06/10/2006 New Pharmacoeconomic Data on TYSABRI(R) Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis04/10/2006 Health Canada Grants Approval of TYSABRI(TM) (natalizumab) for the Treatment of Multiple Sclerosis Following Priority Review29/09/2006 New Data Presented at ECTRIMS Congress Show TYSABRI(R) Has Sustained Effect on Relapse Rate in Multiple Sclerosis Patients Treated for up to Three Years28/09/2006 Research Update27/09/2006 Elan and Transition Therapeutics Inc. Announce Global Collaboration to Develop and Commercialize Alzheimer's Disease Drug AZD-10311/09/2006 Financial Statements09/08/2006 Holding in Company03/08/2006 Holding in Company02/08/2006 Director/PDMR Shareholding02/08/2006 Holding in Company01/08/2006 Interim Results24/07/2006 Biogen Idec and Elan Announce Availability of TYSABRI(R) for the Treatment of Relapsing Forms of Multiple Sclerosis06/07/2006 Elan Signs License Agreement with Abbott for Elan's Proprietary NanoCrystal(R) Technology; To Develop a Single Fixed-Dose Combination of TriCor(R) and Crestor(R) for High Cholesterol Patients05/07/2006 Elan Announces Webcast of Second Quarter 2006 Financial Results29/06/2006 Holding in Company29/06/2006 TYSABRI(R) Receives Approval in European Union for the Treatment of Relapsing Remitting Forms of Multiple Sclerosis21/06/2006 Holding in Company15/06/2006 Holding in Company07/06/2006 Further re Appointment06/06/2006 ERRFDA Approves the Reintroduction of TYSABRI(R) for the Treatment of Relapsing Forms of Multiple Sclerosis01/06/2006 Holding in Company30/05/2006 Director/PDMR Shareholding26/05/2006 Elan Announces the Appointment of a New Board Director25/05/2006 Holding in Companies25/05/2006 Elan Holds Its AGM, All Resolutions Passed25/05/2006 Holding in Company19/05/2006 Director/PDMR Shareholding19/05/2006 Holding in Company19/05/2006 Director Change17/05/2006 Holding in Company12/05/2006 Director/PDMR Shareholding04/05/2006 1st Quarter Results28/04/2006 CHMP Issues Positive Opinion for TYSABRI(R) as a Treatment for Relapsing-Remitting Multiple Sclerosis24/04/2006 Holding in Company20/04/2006 Document Availability19/04/2006 Holding in Company13/04/2006 Annual Information Update 2. Documents filed with United States Securities and Exchange Commission The following documents have been filed with the US Securities and ExchangeCommission and are available on the Edgar website at http://www.sec.gov/edgar/searchedgar/webusers.htm. Date Filing05/04/2007 F-4/A (Amend)Registration of securities, foreign private issuers, business combinations (33 Act)30/03/2007 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)30/03/2007 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)30/03/2007 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)06/03/2007 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)28/02/2007 F-4 Registration of securities, foreign private issuers, business combinations (33 Act)28/02/2007 20-F Annual and transition report of foreign private issuers (Sections 13 or 15(d)) (34 Act)20/02/2007 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)14/02/2007 SC 13G/A (Amend)Statement of acquisition of beneficial ownership by individuals (34 Act)13/02/2007 SC 13G/A (Amend)Statement of acquisition of beneficial ownership by individuals (34 Act)22/01/2007 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)20/12/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)20/12/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)15/12/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)14/12/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)11/12/2006 UPLOAD (Cover)SEC-generated letter22/11/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)17/11/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)15/11/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)09/11/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)01/11/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)25/10/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)24/10/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)16/10/2006 CORRESP (Cover)Correspondence10/10/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)06/10/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)04/10/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)29/09/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)28/09/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)27/09/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)11/09/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)24/08/2006 CORRESP (Cover)Correspondence21/08/2006 UPLOAD (Cover)SEC-generated letter01/08/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)24/07/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)06/07/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)05/07/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)29/06/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)21/06/2006 S-8 Securities to be offered to employees in employee benefit plans (33 Act)21/06/2006 S-8 Securities to be offered to employees in employee benefit plans (33 Act)12/06/2006 SC 13G Statement of acquisition of beneficial ownership by individuals (34 Act)05/06/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)26/05/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)25/05/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)18/05/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)04/05/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)28/04/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act)13/04/2006 6-K Report of foreign issuer (Rules 13a-16 and 15d-16) (34 Act) 3. Documents filed with the Registrar of Companies All of the documents listed below were filed with the Registrar of Companies inIreland on the dates indicated. Copies of documents filed with the Registrar ofCompanies are available from the Companies Registration Office at www.cro.ie. Date Filing26/03/2007 B5 Return of Allotments22/02/2007 B5 Return of Allotments12/02/2007 B6 Particulars of a Contract relating to Shares24/01/2007 B10 Change in Director or Secretary17/01/2007 B6 Particulars of a Contract relating to Shares17/01/2007 B6 Particulars of a Contract relating to Shares17/01/2007 B6 Particulars of a Contract relating to Shares17/01/2007 B6 Particulars of a Contract relating to Shares17/01/2007 B5 Return of Allotments22/12/2006 B5 Return of Allotments27/11/2006 B5 Return of Allotments20/11/2006 B6 Particulars of a Contract relating to Shares08/11/2006 B6 Particulars of a Contract relating to Shares27/10/2006 B1 Annual Return - General27/10/2006 B1 Account Details18/10/2006 B5 Return of Allotments03/10/2006 B5 Return of Allotments25/09/2006 B10 Change in Director or Secretary25/09/2006 B10 Change in Director or Secretary17/08/2006 B10 Change in Director or Secretary15/08/2006 B5 Return of Allotments24/07/2006 B5 Return of Allotments24/07/2006 B5 Return of Allotments05/07/2006 B6 Particulars of a Contract relating to Shares15/06/2006 G1 Special Resolution - Changes to Memorandum and Articles of Association15/06/2006 G1 New Memorandum and Articles of Association14/06/2006 B6 Particulars of a Contract relating to Shares14/06/2006 B6 Particulars of a Contract relating to Shares14/06/2006 B6 Particulars of a Contract relating to Shares14/06/2006 B6 Particulars of a Contract relating to Shares08/06/2006 B10 Change in Director or Secretary30/05/2006 B10 Change in Director or Secretary29/05/2006 B5 Return of Allotments07/04/2006 B5 Return of Allotments 4. Annual and Interim Report 2006 The Company's Annual Report and 20-F for the year ending 31 December 2006 whichwas filed with the Irish Stock Exchange on 30 March 2007, can be found on theCompany's website, as can the Interim Report for the 6 months ended 30 June 2006published on 11 September 2006. A copy of this Annual Information Document and copies of the documents referredto in it can be obtained from the Company Secretary at the Company's RegisteredOffice: Treasury Building, Lower Grand Canal Street, Dublin 2, Ireland. Enquiries: William Daniel Company Secretary +353 1 709 4000 11 April 2007 This announcement has been issued through the Companies Announcement Service of The Irish Stock Exchange. This information is provided by RNS The company news service from the London Stock Exchange